Posts By: Validus Pharmaceuticals

Reintroduction of branded Marplan (isocarboxazid) 10 mg Tablets

Posted by & filed under News.

In 2018 Validus Pharmaceuticals LLC coordinated with the U.S. Food and Drug Administration (FDA) to temporarily import Marplan® (isocarboxacid) from another manufacturer in Denmark (MediLink) in order to alleviate a critical drug shortage of Marplan® (isocarboxazid) 10 mg Tablets for our patients in the United States (US). Validus Pharmaceuticals LLC is pleased to announce that… Read more »

Aytu BioScience and Validus Pharmaceuticals Announce ZolpiMist Co-Promotion Agreement and Launch Into the $163 Million Psychiatry Market

Posted by & filed under News.

Co-Promotion Expands Physician Promotion of Aytu’s Prescription Sleep Aid with Dedicated Specialty Sales Force, into Psychiatry Market, Which Accounted for Over 2.7 Million Zolpidem Tartrate Prescriptions for The Twelve Months Ending August 2019 Aytu’s third announced product co-promotion and has expanded Natesto®, Tuzistra® XR, and ZolpiMist promotional efforts to over 100 sales representatives nationwide ENGLEWOOD,… Read more »

Temporary Supply of Marplan (isocarboxacid) Tablets to Address Critical Drug Shortage

Posted by & filed under News.

Marplan® (isocarboxazid) 10 mg Tablets is currently on FDA’s Drug Shortage List. In order to address the critical shortage of Marplan® in the United States (U.S.) market, Validus Pharmaceuticals LLC has coordinated with the U.S. Food and Drug Administration (FDA) to make Marplan® available to patients in the U.S. who are in desperate need of… Read more »